#Sermorelin

2 stories

Industry April 12, 2026 · View digest

Noom Acquires Tailor Made Compounding, Plans Peptide-Based Therapy Expansion

Wellness platform Noom acquired Tailor Made Compounding (TMC), a licensed 503A pharmacy operating in 46 states, marking its largest investment in healthy aging. Noom plans to expand its formulary to include peptide therapies like sermorelin and GHK-Cu alongside NAD+ and hormone treatments.

Industry April 8, 2026 · View digest

Noom Acquires Compounding Pharmacy TMC to Expand Into Peptide Therapies

Noom acquired Tailor Made Compounding, a licensed 503A pharmacy in 46 states serving 400+ clinics, offering compounded peptides including sermorelin, GHK-Cu, and oxytocin.